Your browser doesn't support javascript.
loading
Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
Robinson, Michael F; Damjanov, Nemanja; Stamenkovic, Bojana; Radunovic, Goran; Kivitz, Alan; Cox, Lori; Manukyan, Zorayr; Banfield, Christopher; Saunders, Michael; Chandra, Deepa; Vincent, Michael S; Mancuso, Jessica; Peeva, Elena; Beebe, Jean S.
Afiliação
  • Robinson MF; California Medical Research Associates, Northridge.
  • Damjanov N; University of Belgrade School of Medicine, Belgrade, Serbia.
  • Stamenkovic B; Institute for Treatment and Rehabilitation Niska Banja and Nis University School of Medicine, Nis, Serbia.
  • Radunovic G; University of Belgrade School of Medicine, Belgrade, Serbia.
  • Kivitz A; Altoona Center for Clinical Research, Duncansville, Pennsylvania.
  • Cox L; Pfizer, Inc., New York, New York.
  • Manukyan Z; Pfizer, Inc., New York, New York.
  • Banfield C; Pfizer, Inc., New York, New York.
  • Saunders M; Pfizer, Inc., New York, New York.
  • Chandra D; Pfizer, Inc., New York, New York.
  • Vincent MS; Pfizer, Inc., New York, New York.
  • Mancuso J; Pfizer, Inc., Groton, Connecticut.
  • Peeva E; Pfizer, Inc., New York, New York.
  • Beebe JS; Pfizer, Inc., New York, New York.
Arthritis Rheumatol ; 72(10): 1621-1631, 2020 10.
Article em En | MEDLINE | ID: mdl-32419304

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Pirimidinas / Pirróis / Antirreumáticos / Inibidores de Proteínas Quinases / Janus Quinase 3 Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Pirimidinas / Pirróis / Antirreumáticos / Inibidores de Proteínas Quinases / Janus Quinase 3 Idioma: En Ano de publicação: 2020 Tipo de documento: Article